CONTENTS:
- Psychedelic experiences and mindfulness are associated with improved wellbeing. Qiu T.T., Minda J.P., p. 123-133.
- Past-year ketamine use: Evidence from a United States population, 2015-2019. Yockey R.A., p. 134-140.
- Ayahuasca ritual, personality and sociality: Observational research conducted in a substance use disorder rehabilitation center in Uruguay. Apud I., Scuro J., Carrera I., Oliveri A., p. 141-150.
- Magic mushroom use: A qualitative interview study of post-trip impacts and strategies for optimizing experiences. Shaw L., Rea K., Lachowsky N.J., Roth E.A., p. 151-158.
- Self-care practices with psychedelics - A qualitative study of users' perspectives. Soares C.M., Leite Â., Pinto M., p. 159-169.
- Validation of a French version of the Mystical Experience Questionnaire with retrospective reports of the most significant psychedelic experience among French users. Fauvel B., Kangaslampi S., Strika-Bruneau L., Roméo B., Piolino P., p. 170-179.
- Illegal drug use, depressive symptoms, and general health: Exploring co-occurrence across 11 years in a national sample. Silver I.A., Kelsay J.D., Lonergan H., p. 180-202.
- Negative affect regulation and marijuana use in college students: Evaluating the mediating roles of coping and sleep motives. Livingston N.R., Hetelekides E., Bravo A.J., Looby A., p. 203-212.
- Predictors of five-year readmission to an inpatient service among patients with opioid use disorders. Ghosh A., Sharma N., Noble D., Basu D., Mattoo S.K., Bhagyalakshmi Nanjayya S., et al., p. 213-223.
- Prevalence of substance use and its association with sociodemographic and behavioral factors among women who conduct sex work in Kenya. Ongeri L., Moshi V., Denckla C.A., Bosire R., Singa B., Otieno P., et al., p. 224-232.
- Efficacy of extended-release injectable naltrexone on alcohol use disorder treatment: A systematic review. Kedia S.K., Ahuja N., Dillon P.J., Jones A., Kumar S., Satapathy S., p. 233-245.